To analyze FBXW7 expression and its relation to the relative abundance of substrates, and with prognostic variables in breast cancer, we performed immunohistochemistry for FBXW7, AURKA, Cyclin E, MCL1 and PLK1 in tissue microarrays containing up to 296 samples of breast carcinomas. This evidence concerns the gene MCL1 and breast carcinoma.